Effects of stromal-derived factor 1 preconditioning on apoptosis of rat bone mesenchymal stem cells

Abstract

The effects of stromal-derived factor 1 preconditioning (PC) on apoptosis of bone mesenchymal stem cells (BMSCs) treated with hypoxia plus serum deprivation were investigated. Bone mesenchymal stem cells were cultured with the whole marrow-adherence technique. RT-PCR and immunohistochemistry were used to detect the expression of CXCR4. BMSCs were incubated in medium for 24 h with 10 ng/mL and 100 ng/mL SDF-1 respectively, and then they were treated with hypoxia plus serum deprivation for 6 h. Apoptosis rate was determined by flow cytometry and TUNEL method. The results showed that BMSCs had CXCR4 expression. The number of apoptotic cells was significantly reduced in SDF-1 PC group as compared with the control group, and 100 ng/mL SDF-1 PC group had the lowest level of apoptosis. It was concluded that SDF-1 preconditioning suppresses the apoptosis of BMSCs treated with hypoxia plus serum deprivation.

Keywords

bone mesenchymal stem cells / SDF-1 / preconditioning / apoptosis

References

[1] PittengerM.F., MackayA.M., BeckS.C., et al.. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284(5411): 143-147

[2] WollertK.C., DrexlerH.. Mesenchymal stem cells for myocardial infarction: promises and pitfalls. Circulation, 2005, 112(2): 151-153

[3] BurchfieldJ.S., DimmelerS.. Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogenesis Tissue Repair, 2008, 1(1): 4

[4] TomaC., PittengerM.F., CahillK.S., et al.. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 2002, 105(1): 93-98

[5] ShakeJ.G., GruberP.J., BaumgartnerW.A., et al.. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Thorac Surg, 2002, 73(6): 1919-1925

[6] GengY.J.. Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure. Ann N Y Acad Sci, 2003, 1010(Apoptosis): 687-697

[7] Cottler-Fox MH, Lapidot T, Petit I, et al. Stem cell mobilization. Hematology Am Soc Hematol Educ Program, 2003:419–437

[8] ZhuW., ChenJ., CongX., et al.. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cell, 2006, 24(2): 416-425

[9] Müller-EhmsenJ., KrausgrillB., BurstV., et al.. Effective engraftment but poor mid-term persistence of mononuclear and mesenehymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol, 2006, 41(5): 876-884

[10] MangiA.A., NoiseuxN., KongD., et al.. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med, 2003, 9(9): 1195-1201

[11] GnecchiM., HeH., LiangO.D., et al.. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med, 2005, 11(4): 367-368

[12] LiW., MaN., OngL.L., et al.. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells, 2007, 25(8): 2118-2127

[13] RosováI., DaoM., CapocciaB.. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells, 2008, 26(8): 2173-2182

[14] NiagaraM.I., HaiderH., JiangS., et al.. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res, 2007, 100(4): 545-555

[15] AiutiA., WebbI.J., BleulC., et al.. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med, 1997, 185(1): 111-120

[16] KimC.H., BroxmeyerH.E.. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood, 1998, 91(1): 100-110

[17] MullerA., HomeyB., SotoH., et al.. Involvement of chemokine receptors in breast cancer metastasis. Nature, 2001, 410(6824): 50-56

[18] YamaguchiJ., KusanoK.F., MasuoO., et al.. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation, 2003, 107(9): 1322-1328

[19] WangY., HaiderH., AhmadN., et al.. Evidence for ischemia induced host-derived bone marrow cell mobilization into cardiac allografts. J Mol Cell Cardiol, 2006, 41(3): 478-487

[20] AskariA.T., UnzekS., PopovicZ.. Beta l effect of stromal cell derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet, 2003, 362(9385): 697-703

[21] BroxmeyerH.E., KohliL., KimC.H., et al.. Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J Leukoc Biol, 2003, 73(5): 630-638

[22] DziembowskaM., ThamT.N., LauP., et al.. A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia, 2005, 50(3): 258-269

[23] JaleelM.A., TsaiA.C., SarkarS., et al.. Stromal cell-derived factor-1 (SDF-1) signalling regulates human placental trophoblast cell survival. Mol Hum Reprod, 2004, 10(12): 901-909

[24] GuoY., HangocG., BianH., et al.. SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells. Stem Cells, 2005, 23(9): 1324-1332

[25] SordiV., MalosioM.L., MarchesiF., et al.. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood, 2005, 106(2): 419-427